Andrea Patriarca

Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

Srđan Verstovšek, Aaron T. Gerds, Alessandro M. Vannucchi et al. · The Lancet · 2023 · 185 citations

Medicine, Hematology, Pharmacology +9

Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer

David J. Pinato, Alberto Zambelli, Mark Bower et al. · Cancer Discovery · 2020 · 183 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study

David J. Pinato, Mark Bower, Lorenza Scotti et al. · The Lancet Oncology · 2021 · 136 citations · Full text

Medicine, Infectious Diseases, Oncology +6

Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial

Tiziano Barbui, Alessandro M. Vannucchi, Valerio De Stefano et al. · The Lancet Haematology · 2021 · 132 citations · Full text

Medicine, Hematology, Pharmacotherapy +6

Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL

Andreas Agathangelidis, Anastasia Chatzidimitriou, Katerina Gemenetzi et al. · Blood · 2020 · 129 citations · Full text

Social Sciences, Oncology, Clinical Classification Systems +12